Investing.com -- Novo Nordisk (NYSE: NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE: LLY) released ...

With President Trump's on-off tariffs causing huge uncertainty in recent weeks, some value stocks have been getting even ...

Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

People with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.

Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...

Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...

Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 (glucagon-like peptide-1) receptor ...

The casual-dining chain’s owners loaded the company up with too much debt coming out of the pandemic. The result was a ...

Discover if eating just 5 specific nuts can actually control hunger all morning long. Science reveals how these ...

For individuals living with type 2 diabetes or struggling with weight loss, Rybelsus has become a popular name in the realm of oral GLP-1 receptor agonists. While its effectiveness in lowering blood ...

Weight loss drugs, already a relatively new and revolutionary concept within the medical industry, are shaking things up once again. Move over Ozempic, pharmaceutical giant Eli Lilly […] ...